| Literature DB >> 89510 |
S W Brusilow, D L Valle, M Batshaw.
Abstract
The defect in nitrogen excretion in patients with inborn errors of urea synthesis can be controlled by exploiting the biosynthetic pathways of readily excretable non-urea metabolites which contain nitrogen derived from ammonium, alanine, glutamate, and glutamine. Two classes of such metabolites are the urea-cycle intermediates--including citrulline, argininosuccinic acid, and arginine--and the aminoacid acylation products--hippuric acid (the glycine conjugate of benzoic acid) and phenylactylglutamine (the glutamine conjugate of phenylactic acid). Thus the urea cycle may serve as a model for the development of excretion pathways of toxic precursors which accumulate in inborn errors of metabolism.Entities:
Mesh:
Substances:
Year: 1979 PMID: 89510 DOI: 10.1016/s0140-6736(79)91503-4
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321